Financial News
All News about Genmab A/S ADR
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Ratings For Genmab
March 26, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://mms.businesswire.com/media/20240227092202/en/2045857/5/Genmab_Logo_Color_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
4 Analysts Assess Genmab: What You Need To Know
February 20, 2024
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Genmab
February 13, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://mms.businesswire.com/media/20240202549142/en/2018874/22/GenmabLogo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Cracking The Code: Understanding Analyst Reviews For Genmab
January 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/Gavel-law-Image-by-Okan-Caliskan-from-Pi_2.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
9 Analysts Have This to Say About Genmab
November 28, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Genmab's Future
November 08, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20240105049976/en/1989817/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20240109858951/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/oracle_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231208348497/en/1964677/5/Genmab_Logo_Color_RGB.jpg)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://mms.businesswire.com/media/20231126633910/en/1952547/5/Genmab_Logo_Color_RGB.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/cheap-retail-stocks.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20231102484885/en/1932449/5/Genmab_Logo_Color_RGB.jpg)
![](https://mms.businesswire.com/media/20231017331126/en/828587/5/Seagen_Logo_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.